Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-04

Clinical Trial Update: Feasibility Study: tDCS for Treatment of Refractory Status Epilepticus [NA]

View source ↗

Summary

A feasibility study evaluating transcranial direct current stimulation (tDCS) for refractory status epilepticus has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Yale University | Conditions: Status Epilepticus, Refractory Status Epilepticus | NA | Status: TERMINATED